Stocks to buy

As the battle for the electric vehicle market heats, more companies are emerging to try to take the crown from Tesla (NASDAQ:TSLA). Multiple competitors are targeting very specific niches in order to take market share away from the EV giant. One company that caught my eye is Lucid Motors (NASDAQ:LCID), which is targeting the extremely

Rejection can be painful, especially if you’re a longtime investor in Canadian cannabis company Sundial Growers (NASDAQ:SNDL). Time and again, SNDL stock has flirted with the key $1 level, but gravity keeps pulling it back down. Source: Postmodern Studio / Shutterstock.com I’ll admit, I recommended a patient stance on Sundial Growers in July, and my timing wasn’t perfect.

For anyone interested in the Internet of Things, also known as IoT, you should consider an exciting company known as Focus Universal (NASDAQ:FCUV). In recent weeks, FCUV stock has been getting a lot of attention — and for all the right reasons. Source: Shutterstock Why get involved in IoT as an investor? According to the company,

Novavax (NASDAQ:NVAX) released its second-quarter results on Aug. 5 and updated the market on its Covid-19 vaccine progress. Their Covid candidate has performed well in its Phase 3 trials and the company expects to apply for emergency use authorization (EUA) for distribution in the U.S. during Q4. As a result, it looks like NVAX stock

Roku (NASDAQ:ROKU) is still a growth stock, despite the fact that it’s been falling lately. In fact, in my last article on ROKU stock, I wrote that it could end up falling some 20% to 30% from Aug. 11. That was when it was at $369.21. Since then, it has fallen 9%. Source: Michael Vi

Backed against the wall by the rise of Taiwan Semiconductor (NYSE:TSM), Intel (NASDAQ:INTC) is putting all its financial chips (and more) on the line, which has big implications for INTC stock. Source: dennizn / Shutterstock.com CEO Pat Gelsinger has promised to bring half the semiconductor industry to the U.S. and Europe if governments cooperate. China’s

While some investors like to manage their portfolios actively, others prefer to buy stocks under $100 for the long term. This means holding onto shares for as long as thirty years, or even forever. However, you can’t hold just any stock indefinitely. Plenty of companies seem like a great bet one year, only to plummet

Casual onlookers may have a hard time digesting the broader implications of the virtual reality sector. Having personally stepped into the realm of digitalized ecosystems, I can tell you the practice takes some getting used to. At the same time, innovation is constantly moving forward, which makes the investment case for virtual reality stocks an

Navigating the markets can be a tough task these days. According to the stock market capitalization to gross domestic product (GDP) ratio, today’s U.S. stock market is 100% overvalued. But even though you can disagree with the extent, most will agree the U.S. stock market is far from cheap at the moment. In these circumstances,

Roku’s (NASDAQ:ROKU) growth outlook remains extremely strong. And that means the recent, unwarranted downturn of ROKU stock has created a great buying opportunity for longer-term investors. Source: Michael Vi / Shutterstock.com Over the last month, the shares have given back 13%. The downturn appears to have been driven by Roku’s weaker-than-expected Q2 user metrics. A

Given the incredible advancements of modern technologies, it’s no surprise that many analysts and investors regard precious metals as barbaric relics that serve little relevance. On some levels, I can appreciate their point. Buying gold stocks might seem like going for a bunt in a baseball game. Let’s face it — people are paying money

After fuboTV (NYSE:FUBO) reported second-quarter earnings this month, I wrote in this space that I continued to have high hopes for FUBO stock. Source: monticello / Shutterstock.com The New York-based streaming television service was coming off an excellent earnings report, but I was more impressed with the company’s plan to grow its sportsbook offerings. “The

Vaxart (NASDAQ:VXRT) stock is a high-risk Covid-19 vaccine play. But unlike some other small-cap long-shots, like Ocugen (NASDAQ:OCGN), it has a lot more going for it. Source: Photo courtesy of Vaxart, Inc. For starters, developing its candidate itself, unlike Ocugen, this clinical-stage biotech company has more avenues to find success even if it fails to

Prior to the meme-trading phenomenon, I supported the contrarian bullish case for cineplex operator AMC Entertainment (NYSE:AMC). In the many years leading up to the Covid-19 pandemic, streaming companies like Netflix (NASDAQ:NFLX) had been siphoning market share from the box office. Naturally, this dynamic put intense pressure on AMC stock. Source: QualityHD / Shutterstock.com Nevertheless,

Cybersecurity gained prominence as digitalization became a buzz word during the pandemic. A recent FBI report cites cyber-scam figures that reached 791,790 incidents in the past year, with losses exceeding $4.2 billion. The surge in attacks has spurred businesses and governments to increase their spending on protection, creating a significant tailwind for some cybersecurity stocks.

With a bipartisan infrastructure bill and a $3.5 trillion budget resolution making their way through Congress and looking poised to pass, I believe investors are greatly underestimating the extent to which these pieces of legislation will help General Electric (NYSE:GE) and GE stock. Source: Sundry Photography / Shutterstock.com GE operates through four industrial segments — Power,

Folks who know me will tell you that I’m not just an “innovation investor” – I’m an “innovation guy.” That is, I don’t just invest in innovative stocks to make a lot of money. I also use innovative new services and products every single day to make my life better. I, quite literally, live and

Novavax (NASDAQ:NVAX) stock could trade in the $100 billion market capitalization range like BioNTech (NASDAQ:BNTX) or Moderna (NASDAQ:MRNA). Except, unlike those companies, Novavax has not yet delivered. Source: Ascannio/Shutterstock.com It might be among the most-watched firms that did not yet bring a Covid-19 vaccine to market. Chances are low that it will slump like Altimmune

Timing a market bottom is a notoriously difficult thing to do. So, I won’t claim that now is the definitive time to invest in Alibaba (NYSE:BABA) stock. Source: Kevin Chen Photography / Shutterstock.com However, pundits have to admit that the case for maximizing returns by buying low looks very near.  The truth is that Alibaba

Allegations of fraud against Cassava Sciences (NASDAQ:SAVA) are unlikely to stop its Alzheimer’s drug candidate from quickly advancing to a Phase 3 clinical trial. As a result, I remain very bullish on SAVA stock. Source: Shutterstock One of the most important reasons is an issue that hasn’t been explored very much yet. Specifically, none of